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Down syndrome (DS) is caused by trisomy of chromosome 21, and affects 1/700 live births. DS 
results in about 80 clinical phenotypes, including cognitive impairment. DYRK1A, a chromosome 
21 gene, has been linked to alterations in morphology and function of the brain resulting in 
cognitive impairment. Epigallocatechin-3-gallate (EGCG), an inhibitor of DYRK1A activity, has 
been proposed as a possible treatment for cognitive deficits seen in individuals with DS. Using 
the Ts65Dn DS mouse model, we examined the effects of EGCG treatment on cerebellum 
dependent tasks using a balance beam test. We hypothesized that treatment with EGCG would 
improve Ts65Dn performance on the balance beam. In a first experiment, mice were given a 
dose of ~30 mg/kg/day EGCG, which showed no significant improvement in the balance beam 
task. In a second experiment, mice were given a dose of 100 mg/kg/day EGCG or water (control) 
starting at 3 weeks of age. The mice were handled two days before testing and then underwent a 
series of behavioral tasks including the balance beam test. The mice traversed three beams of 
differing widths (12, 9 and 6 mm), and three consecutive trials for each were recorded for further 
analysis. The balance beam recordings were scored by three independent scorers, blind to 
genotype and treatment, and the number of hind paw slips for each trial were scored. Our 
preliminary results indicate that the Ts65Dn mice are impaired at this task and have more hind 
paw slips compared to euploid controls. A larger number of animals should help to distinguish 
any differences in Ts65Dn mice due to EGCG treatment.  
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